News feed

FloVitro

Our latest webinar is now available to watch on demand

By Rebecca Heys
- 31 March | 2017

 Originally broadcast live on Wednesday 22nd March 2016, our latest webinar is now available to view on demand. Entitlted "FloVitro™: Evaluate the dissolution of dosage forms under biorelevant conditions" and presented by Hayley Watson,... Read more

Webinar - FloVitro™: Evaluate the dissolution of dosage forms under biorelevant conditions

By Rebecca Heys
- 09 March | 2017

DATE: 22 MARCH 2017 | TIME: 15:00 GMTSirius Analytical, in collaboration with the Dow Chemical Company, are proud to announce the latest edition of our popular webinar series.Once a test method has been developed for a given API, that same test method may be... Read more

The Tablet Optimisation Lab

By Rebecca Heys
- 21 February | 2017

Aimed at originators and generic companies alike, our new consultancy service provides customers with valuable insights into their solid oral dosage forms. We aim to enable our clients to make faster and better informed decisions about dosage form progression... Read more

Dow Pharma and Food Solutions (DPFS) and Sirius Analytical Announce Strategic Agreement

By Rebecca Heys
- 15 November | 2016

Dow Pharma and Food Solutions (DPFS) and Sirius Analytical Announce Strategic Agreement to Offer Biorelevant Equivalence Testing on FloVitro™ PlatformLondon, UK and Midland, MI, 14 November 2016 – Dow Pharma and Food Solutions, a business unit... Read more